ORAFOL Unveils €235 Million Investment Plan Under ‘Roadmap 2030’

ORAFOL has announced a €235 million investment program at its German headquarters as part of its “ORAFOL Roadmap 2030 – Shaping the Future,” which outlines global expansion plans through 2030.

The investment will support new production capacity, including the upcoming groundbreaking of Production Complex Hall 14 in May 2026, alongside broader expansion across Europe, the Americas and Asia-Pacific.

The company is also advancing international growth initiatives, including a memorandum of understanding signed in April 2026 for a new production facility in Korea. The first phase of the project is expected to attract investment exceeding USD 60 million in the Seoul region.

ORAFOL said the roadmap reinforces its commitment to innovation and sustainability, while strengthening its position as a key industrial partner in its home region and globally.

Dr Holger Loclair, Chairman & CEO of ORAFOL Group, said the strategy balances local commitment with international growth ambitions, saying, “The ORAFOL Roadmap 2030, with its investment initiative, reflects my optimism and represents a commitment to our home base in Germany. At the same time, we have built up the strength to consistently pursue our growth globally through investments. Both are crucial to our goal of remaining one of the market leaders.”

In addition to the headquarters investment, ORAFOL is expanding operations at subsidiaries including ORAFOL Americas in the U.S., Group M.A.M. in Belgium, and Reflomax in Korea, underscoring its focus on long-term global competitiveness.